Syncell, a leader in next-generation subcellular protein purification and spatial proteomics analysis, announced the close of a $15 million Series A funding round, bringing its total raised to $30 million. The investment will be used to expand and accelerate the global commercialization and commercial support for the company's groundbreaking Microscoop platform. The round was led by Taiwania Capital, with participation from new and existing investors.